Triptolide Reduces MDA‐MB‐231 Cell Metastasis by Attenuating Epithelial‐Mesenchymal Transition through the ROCK/PTEN/Akt Axis

Author:

Wu Qinhang1ORCID,Leng Xuejiao1,Ma Xuelin1,Xu Qixuan1,Ni Ruijun1,Pan Yang1,Jin Zhuolin1,Kalim Muhammad2

Affiliation:

1. School of Pharmacy Nanjing University of Chinese Medicine Nanjing 210023 P.R. China

2. Department of Microbiology and Immunology Wake Forest University Winston-Salem, NC 27101 USA

Abstract

AbstractTriple‐negative breast cancer (TNBC) is a highly heterogeneous and invasive subtype of breast cancer. The prognosis of TNBC is poor because of its high distant metastasis rate. Triptolide is a type of diterpene trioxide natural compound with potential anti‐tumor activities. This study explored the metastatic inhibitory effect of triptolide on MDA‐MB‐231 cells and its underlying mechanism. Triptolide suppressed cell proliferation and induced cell apoptosis in a time‐ and dose‐dependent manner. Low doses of triptolide (0‐8 nM) reduced the migration and invasion capabilities of MDA‐MB‐231 cells. Triptolide decreased ROCK1, p‐Akt, N‐cadherin, vimentin and MMP‐9 expressions, but increased PTEN and E‐cadherin expressions on protein and mRNA levels. Furthermore, the down‐regulation of ROCK1 expression in MDA‐MB‐231 cells after being treated by triptolide could be rescued by ROCK1 specific inhibitor Y27632. Molecular docking showed that triptolide and Y27632 shared the same active center of ROCK1 protein. This article‘s findings taken together showed that ROCK1 is the primary target of triptolide, which can cause cell apoptosis and inhibit the epithelial‐mesenchymal transition of MDA‐MB‐231 cells.

Funder

National Natural Science Foundation of China

Nanjing University of Chinese Medicine

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3